Intuniv XR (guanfacine hydrochloride)

pCPA File Number: 20854
Negotiation Status:
Negotiations were not pursued
Indication(s):
Attention-deficit/hyperactivity disorder (ADHD)
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CADTH Project Number:
SR0349-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: